AKOUOS

akouos-logo

Akouos is a biotechnology company focusing on restoring and preserving hearing. The company leverages adeno-associated viral (AAV) vector-based gene therapy in order to restore and preserve hearing in genetically-defined patient populations in a range of forms, from a single genetic mutation to ototoxic drug exposure and to the aging process, enabling the healthcare industry to treat sensorineural hearing loss in an efficient manner.

#SimilarOrganizations #People #Financial #Event #Website #More

AKOUOS

Social Links:

Industry:
Biotechnology Health Diagnostics Pharmaceutical

Founded:
2016-01-01

Address:
Boston, Massachusetts, United States

Country:
United States

Website Url:
http://www.akouos.com

Total Employee:
101+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
162.5 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Analytics Global Site Tag IPv6 Google Analytics 4


Similar Organizations

1859-logo

1859

1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.

arrowhead-pharmaceuticals-logo

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.

novellus-logo

Novellus

Novellus is a biotechnology company working to develop engineered cellular medicines.

syros-pharmaceuticals-logo

Syros Pharmaceuticals

Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.


Current Advisors List

ed-mathers_image

Ed Mathers Board Of Director @ Akouos
Board_member

kush-parmar_image

Kush Parmar Board of Director @ Akouos
Board_member
2017-11-01

not_available_image

Vicki Sato Director of the Board @ Akouos
Board_member

aaron-tward_image

Aaron Tward Scientific Advisory Board @ Akouos
Advisor

heather-preston_image

Heather Preston Board Member @ Akouos
Board_member
2020-03-31

Current Employees Featured

manny-simons_image

Manny Simons
Manny Simons Founder and Chief Executive Officer @ Akouos
Founder and Chief Executive Officer
2016-08-01

michael-mckenna_image

Michael McKenna
Michael McKenna Chief Medical Officer and Co-Founder @ Akouos
Chief Medical Officer and Co-Founder

karoline-shair_image

Karoline Shair
Karoline Shair Chief Legal Officer and Corporate Secretary @ Akouos
Chief Legal Officer and Corporate Secretary
2019-11-01

jennifer-a-wellman_image

Jennifer A. Wellman
Jennifer A. Wellman COO @ Akouos
COO

gregory-robinson_image

Gregory Robinson
Gregory Robinson CSO @ Akouos
CSO

colleen-tucker_image

Colleen Tucker
Colleen Tucker Vice President, Human Resources @ Akouos
Vice President, Human Resources
2021-12-01

luk-vandenberghe_image

Luk Vandenberghe
Luk Vandenberghe Co-Founder & Scientific Advisory Board @ Akouos
Co-Founder & Scientific Advisory Board
2017-12-01

aaron-tward_image

Aaron Tward
Aaron Tward Chief Scientific Officer @ Akouos
Chief Scientific Officer
2022-03-01

Founder


manny-simons_image

Manny Simons

michael-mckenna_image

Michael McKenna

Stock Details


Company's stock symbol is NASDAQ:AKUS

Investors List

fidelity-investments_image

Fidelity

Fidelity investment in Series B - Akouos

pag_image

PAG

PAG investment in Series B - Akouos

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Series B - Akouos

polaris-founders-capital_image

Polaris Founders Capital

Polaris Founders Capital investment in Series B - Akouos

novartis-venture-fund_image

Novartis Venture Fund

Novartis Venture Fund investment in Series B - Akouos

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series B - Akouos

pivotal-bioventure-partners_image

Pivotal bioVenture Partners

Pivotal bioVenture Partners investment in Series B - Akouos

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series B - Akouos

surveyor-capital_image

Surveyor Capital

Surveyor Capital investment in Series B - Akouos

wu-capital_image

Wu Capital

Wu Capital investment in Series B - Akouos

Key Employee Changes

Date New article
2022-03-10 Akouos Appoints Aaron Tward, M.D., Ph.D., as Chief Scientific Officer

Official Site Inspections

http://www.akouos.com Semrush global rank: 2.96 M Semrush visits lastest month: 5.3 K

  • Host name: 104.18.33.196
  • IP address: 104.18.33.196
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Akouos"

Akouos โ€“ Our Mission: Healthy Hearing Available to All

Our Mission: Healthy Hearing Available to All. We are a precision genetic medicine company focused on developing gene therapies with the potential to restore, improve and preserve high โ€ฆSee details»

Akouos - Crunchbase Company Profile & Funding

Akouos is a biotechnology company focusing on restoring and preserving hearing. The company leverages adeno-associated viral (AAV) vector-based gene therapy in order to restore and โ€ฆSee details»

Akouos - LinkedIn

Akouos wishes you a joyous holiday season filled with laughter, light, and happy times with loved ones. โ€ฆmoreSee details»

Lilly Completes Acquisition of Akouos Expanding Efforts to Help โ€ฆ

INDIANAPOLIS, Dec. 1, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Akouos, Inc. (NASDAQ: AKUS). The โ€ฆSee details»

Our Focus โ€“ Akouos

The Akouos founding team has over 100 years of combined research experience characterizing inner ear structure-function relationships. The work of co-founder Dr. Richard J. Smith, โ€ฆSee details»

Akouos - Funding, Financials, Valuation & Investors - Crunchbase

Akouos is registered under the ticker NASDAQ:AKUS . Their stock opened with $17.00 in its Jun 25, 2020 IPO. Akouos is funded by 15 investors. Fidelity and PAG are the most recent โ€ฆSee details»

Akouos - Org Chart, Teams, Culture & Jobs - The Org

Akouos is a precision genetic medicine company focused on developing gene therapies with the potential to restore, improve and preserve high-acuity physiologic hearing. Industries. โ€ฆSee details»

Akouos Company Profile - Office Locations, Competitors ... - Craft

Akouos is a precision genetic medicine company focused on developing gene therapies to treat hearing disorders. It advances candidate therapies that target sensory cells, such as inner hair โ€ฆSee details»

Akouos - VentureRadar

" Akouos is a precision genetic medicine company dedicated to developing gene therapies with the potential to restore, improve, and preserve high-acuity physiologic hearing for individuals โ€ฆSee details»

Akouos - Contacts, Employees, Board Members, Advisors

Organization. Akouos . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 8. Number of Board โ€ฆSee details»

Akouos - Overview, News & Similar companies | ZoomInfo.com

Who is Akouos. Akouos is a precision genetic medicine company dedicated to developing gene therapies with the potential to restore, improve, and preserve high-acu ity physiologic hearing โ€ฆSee details»

Emmanuel Simons - CEO, President & Co-Founder at Akouos

Emmanuel J. (Manny) Simons, Ph.D., M.B.A., is CEO, President, and Co-Founder of Akouos. Dr. Simons is a scientist and entrepreneur with over fifteen years of experience in hearing science โ€ฆSee details»

Lilly to Acquire Akouos to Discover and Develop Treatments for โ€ฆ

Oct 18, 2022 Akouos has integrated expertise across otology, inner ear drug delivery, and gene therapy with the goal of addressing the needs of people living with disabling hearing loss โ€ฆSee details»

Akouos Announces Expansion of Executive Team and Board of โ€ฆ

Aug 5, 2020 incorporates a proprietary adeno-associated viral (AAV) vector library and a novel delivery approach, Akouos is focused on developing precision therapies for forms of โ€ฆSee details»

Akouos - 2025 Company Profile, Funding & Competitors - Tracxn

Mar 28, 2025 Akouos is an acquired company based in Boston (United States), founded in 2016 by Manny Simons. It operates as a Developer of gene therapies to restore and preserve โ€ฆSee details»

Startup Akouos Raises Millions for Sensorineural Hearing Loss โ€ฆ

Aug 17, 2018 Akouos is focused on developing treatment for monogenic forms of sensorineural hearing loss (SNHL). SNHL, which accounts for 90 percent of hearing loss cases, is caused by โ€ฆSee details»

Akouos - Updates, News, Events, Signals & Triggers - Crunchbase

Akouos may be growing as it was acquired by Eli Lilly for $500 million, indicating a significant valuation and investment in the company's potential. The acquisition by a major โ€ฆSee details»

Akouos - workinbiotech.com

Akouos is developing AAV-based gene therapies to treat hearing loss that results from mutations in genes for inner ear function. Akouos uses specialized vectors and surgical procedures to โ€ฆSee details»

Akouos investor presentations, pitch decks, slides and documents ...

Akouos Presentations & Investor Relations material Our Mission: Healthy Hearing Available to All We are a precision genetic medicine company focused on developing gene therapies with the โ€ฆSee details»

Akouos Reports First Quarter 2022 Financial Results and Provides ...

May 12, 2022 incorporates a proprietary adeno-associated viral (AAV) vector library and a novel delivery approach, Akouos is focused on developing precision therapies for forms of โ€ฆSee details»

linkstock.net © 2022. All rights reserved